Modeling multiple variations of a typical gene-modified cell therapy facility enables both a thorough examination of company and industry-wide challenges, and exploration of alternative/future models for the cell & gene therapy manufacturing sector. This presentation educates attendees on the different technologies, layouts and delivery options available.
Watch this On Demand webinar with Marc Pelletier, PhD, Director, Strategic Consulting, CRB and Ryan McDonough, Senior Associate, Biotechnology Core Team Leader, CRB, as they discuss how to: